A Phase II rectal safety and adherence study of a reformulated version of -tenofovir gel and oral Truvada® that will include approximately 186 men who have sex with men and transgendered women. The study, which is being developed, will be conducted at sites in the U.S., Peru, South Africa and Thailand.
See
